Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching.
Linde L, Ørnbjerg LM, Heegaard Brahe C, Wallman JK, Di Giuseppe D, Závada J, Castrejon I, Díaz-Gonzalez F, Rotar Z, Tomšič M, Glintborg B, Gudbjornsson B, Geirsson AJ, Michelsen B, Kristianslund EK, Santos MJ, Barcelos A, Nordström D, Eklund KK, Ciurea A, Nissen M, Akar S, Hejl Hyldstrup L, Krogh NS, Hetland ML, Østergaard M. Linde L, et al. Among authors: akar s. Rheumatology (Oxford). 2024 Jul 1;63(7):1882-1892. doi: 10.1093/rheumatology/kead494. Rheumatology (Oxford). 2024. PMID: 37738257 Free PMC article.
The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis.
Tuğsal HY, Artin GK, Can G, Çapar S, Zengin B, Akar S, Dalkiliç HE, Şenel AS, Koca SS, Göker B, Yazici A, İnanç GN, Ellidokuz H, Akkoç N, Önen F. Tuğsal HY, et al. Among authors: akar s. Turk J Med Sci. 2023 Aug;53(4):970-978. doi: 10.55730/1300-0144.5661. Epub 2023 Aug 18. Turk J Med Sci. 2023. PMID: 38031953 Free PMC article.
Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.
Karakaş A, Gulle S, Can G, Dalkılıc E, Akar S, Koca SS, Pehlivan Y, Senel S, Tufan A, Ozturk MA, Yilmaz S, Yazici A, Cefle A, Yüce İnel T, Erez Y, Sari I, Birlik M, Direskeneli H, Akkoc N, Onen F. Karakaş A, et al. Among authors: akar s. Mod Rheumatol. 2024 Mar 28;34(3):584-591. doi: 10.1093/mr/road061. Mod Rheumatol. 2024. PMID: 37348053
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.
Karadag O, Farisogullari B, Yagiz B, Erden A, Ademoglu Z, Kimyon G, Bilge NS, Icacan OC, Kilic L, Coskun BN, Ersozlu ED, Kucuksahin O, Mercan R, Koca SS, Gonullu E, Cinar M, Akar S, Emmungil H, Kasifoglu T, Bes C, Omma A, Pehlivan Y, Kiraz S, Ertenli I, Dalkilic E, Kalyoncu U. Karadag O, et al. Among authors: akar s. Clin Exp Rheumatol. 2024 Jan;42(1):130-137. doi: 10.55563/clinexprheumatol/2h6ma1. Epub 2023 Aug 29. Clin Exp Rheumatol. 2024. PMID: 37650346 Free article.
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Inanc N, et al. Among authors: akar s. J Clin Rheumatol. 2023 Dec 1;29(8):365-369. doi: 10.1097/RHU.0000000000002026. Epub 2023 Sep 19. J Clin Rheumatol. 2023. PMID: 37724891 Free PMC article.
A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry.
Yazici A, Özdemir Işık Ö, Dalkılıç E, Koca SS, Pehlivan Y, Şenel S, Inanc N, Akar S, Yılmaz S, Soysal Gündüz Ö, Cefle A, Karakaş ÖF, Onen F. Yazici A, et al. Among authors: akar s. Sci Rep. 2022 Dec 20;12(1):21972. doi: 10.1038/s41598-022-26106-0. Sci Rep. 2022. PMID: 36539458 Free PMC article.
549 results